Cheng Huang

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma.
  2025 L1 66/100

1 assessed by us (0 reproduced) · 38 not yet assessed — every PubMed paper on record, linked below.

• Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma

  Nature Communications · 2025 · PMID 41387425
  L1 66/100
• Thermoelectric Optimisation of Park-Level Integrated Energy System Considering Two-Stage Power-to-Gas and Source-Load Uncertainty ↗

  Processes · 2025
  not yet assessed
• ECom-Bench: Can LLM Agent Resolve Real-World E-commerce Customer Support Issues? ↗

  2025
  not yet assessed
• Data from ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis ↗

  2025
  not yet assessed
• Supplementary Data from ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis ↗

  2025
  not yet assessed
• Immune-related pathologic response (irPR) features and immunotherapeuticresponse score (ITRS) to predict survival following neoadjuvant combined immunotherapy in hepatocellular carcinoma. ↗

  Journal of Clinical Oncology · 2025
  not yet assessed
• ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis ↗

  Cancer Research · 2024 · PMID 39495239
  not yet assessed
• CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway ↗

  Hepatology International · 2024 · PMID 38769286
  not yet assessed
• Single-cell and spatial architecture of primary liver cancer ↗

  Communications Biology · 2023 · PMID 37985711
  not yet assessed
• Mitochondrial supercomplex assembly regulates metabolic features and glutamine dependency in mammalian cells ↗

  Theranostics · 2023 · PMID 37351168
  not yet assessed
• A novel myeloid cell marker genes related signature can indicate immune infiltration and predict prognosis of hepatocellular carcinoma: Integrated analysis of bulk and single-cell RNA sequencing ↗

  Frontiers in Molecular Biosciences · 2023 · PMID 36959981
  not yet assessed
• A <scp><i>ScWIP5</i></scp> gene confers fall armyworm resistance by reducing digestive enzyme activities in sugarcane ↗

  Pest Management Science · 2023 · PMID 38072905
  not yet assessed
• Sintilimab combined with bevacizumab biosimilar as a conversion therapy in potentially resectable intermediate-stage hepatocellular carcinoma (HCC): Updated results of a phase II trial. ↗

  Journal of Clinical Oncology · 2023
  not yet assessed
• Supplementary Figure from IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment ↗

  2023
  not yet assessed
• Supplementary Figure from IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment ↗

  2023
  not yet assessed
• IFNα Potentiates Anti–PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment ↗

  Cancer Discovery · 2022 · PMID 35412588
  not yet assessed
• Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma ↗

  Hepatology · 2022 · PMID 35243663
  not yet assessed
• ZNF191 alters DNA methylation and activates the PI3K‐AKT pathway in hepatoma cells via transcriptional regulation of <i>DNMT1</i> ↗

  Cancer Medicine · 2022 · PMID 35092191
  not yet assessed
• Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice ↗

  Biochemical Pharmacology · 2022 · PMID 35395241
  not yet assessed
• Untitled Item ↗

  Figshare · 2022
  not yet assessed
• Additional file 4 of Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification ↗

  Open MIND · 2022
  not yet assessed
• Additional file 3 of Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification ↗

  Figshare · 2022
  not yet assessed
• All_source_data ↗

  Figshare · 2022
  not yet assessed
• Additional file 2 of Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification ↗

  Figshare · 2022
  not yet assessed
• Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B‐related hepatocellular carcinoma ↗

  Clinical and Translational Medicine · 2021 · PMID 33783990
  not yet assessed
• CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression ↗

  Carcinogenesis · 2021 · PMID 34314478
  not yet assessed
• Organ Specific Responses to First-line Lenvatinib Plus Anti-PD-1 Antibodies in Patients With Unresectable Hepatocellular Carcinoma: a Retrospective Analysis ↗

  Research Square · 2021
  not yet assessed
• Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis ↗

  BioMed Research International · 2020 · PMID 32280695
  not yet assessed
• Wnt8B, transcriptionally regulated by ZNF191, promotes cell proliferation of hepatocellular carcinoma via Wnt signaling ↗

  Cancer Science · 2020 · PMID 33197287
  not yet assessed
• CircRNA UBAP2 Serves as a Sponge of miR-1294 to Increase Tumorigenesis in Hepatocellular Carcinoma through Regulating c-Myc Expression ↗

  Research Square · 2020
  not yet assessed
• CircRNA UBAP2 Serves as a Sponge of miR-1294 to Increase Tumorigenesis in Hepatocellular Carcinoma through Regulating c-Myc Expression ↗

  Research Square · 2020
  not yet assessed
• Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma ↗

  Nature · 2019 · PMID 30814741
  not yet assessed
• eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulation. ↗

  PubMed · 2019 · PMID 31218114
  not yet assessed
• Secreted frizzled-related protein 2-mediated cancer events: Friend or foe? ↗

  Pharmacological Reports · 2017 · PMID 28273499
  not yet assessed
• MicroRNA let-7a: a novel therapeutic candidate in prostate cancer ↗

  Asian Journal of Andrology · 2014 · PMID 24480926
  not yet assessed
• MicroRNA-216a: a potential therapeutic target for drug resistance and recurrent liver cancer ↗

  Hepatobiliary & pancreatic diseases international · 2013 · PMID 24322754
  not yet assessed
• Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma: [RETRACTED] # ↗

  Hepatology · 2008 · PMID 19053044
  not yet assessed
• Local Expression of Secondary Lymphoid Tissue Chemokine Delivered by Adeno-Associated Virus within the Tumor Bed Stimulates Strong Anti-Liver Tumor Immunity ↗

  Journal of Virology · 2007 · PMID 17567706
  not yet assessed
• Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma ↗

  Journal of Cancer Research and Clinical Oncology · 2007 · PMID 17828420
  not yet assessed